APA (7th ed.) Citation

Vultaggio, A., Petroni, G., Pratesi, S., Nencini, F., Cammelli, D., Milla, M., . . . Matucci, A. (2016). Circulating T cells to infliximab are detectable mainly in treated patients developing anti‐drug antibodies and hypersensitivity reactions. Clinical and experimental immunology, 186(3), 364-372. https://doi.org/10.1111/cei.12858

Chicago Style (17th ed.) Citation

Vultaggio, A., et al. "Circulating T Cells to Infliximab Are Detectable Mainly in Treated Patients Developing Anti‐drug Antibodies and Hypersensitivity Reactions." Clinical and Experimental Immunology 186, no. 3 (2016): 364-372. https://doi.org/10.1111/cei.12858.

MLA (9th ed.) Citation

Vultaggio, A., et al. "Circulating T Cells to Infliximab Are Detectable Mainly in Treated Patients Developing Anti‐drug Antibodies and Hypersensitivity Reactions." Clinical and Experimental Immunology, vol. 186, no. 3, 2016, pp. 364-372, https://doi.org/10.1111/cei.12858.